Cargando…
A bibliometrics and visualization analysis of cannabidiol research from 2004 to 2021
Cannabidiol, a non-psychoactive component extracted from the plant cannabis sativa, has gained growing focus in recent years since its extensive pharmacology effects have been founded. The purpose of this study intends to reveal the hot spots and frontiers of cannabidiol research using bibliometrics...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673983/ https://www.ncbi.nlm.nih.gov/pubmed/36408229 http://dx.doi.org/10.3389/fphar.2022.969883 |
_version_ | 1784833061151571968 |
---|---|
author | Liu, Liu Liu, Jianxing Zhao, Ming Cai, Meiming Lei, Fanzhang Zeng, Xiaofeng Zhu, Bofeng |
author_facet | Liu, Liu Liu, Jianxing Zhao, Ming Cai, Meiming Lei, Fanzhang Zeng, Xiaofeng Zhu, Bofeng |
author_sort | Liu, Liu |
collection | PubMed |
description | Cannabidiol, a non-psychoactive component extracted from the plant cannabis sativa, has gained growing focus in recent years since its extensive pharmacology effects have been founded. The purpose of this study intends to reveal the hot spots and frontiers of cannabidiol research using bibliometrics and data visualization methods. A total of 3,555 publications with 106,793 citations from 2004 to 2021 related to cannabidiol were retrieved in the Web of Science database, and the co-authorships, research categories, keyword burst, and reference citations in the cannabidiol field were analyzed and visualized by VOSviewer and Citespace software. Great importance has been attached to the pharmacology or pharmacy values of cannabidiol, especially in the treatment of neuropsychiatric disorders, such as epilepsy, anxiety, and schizophrenia. The mechanisms or targets of the cannabidiol have attracted the extreme interest of the researchers, a variety of receptors including cannabinoids type 1, cannabinoids type 2, 5-hydroxytriptamine1A, and G protein-coupled receptor 55 were involved in the pharmacology effects of cannabidiol. Moreover, the latest developed topic has focused on the positive effects of cannabidiol on substance use disorders. In conclusion, this study reveals the development and transformation of knowledge structures and research hotspots in the cannabidiol field from a bibliometrics perspective, exploring the possible directions of future research. |
format | Online Article Text |
id | pubmed-9673983 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-96739832022-11-19 A bibliometrics and visualization analysis of cannabidiol research from 2004 to 2021 Liu, Liu Liu, Jianxing Zhao, Ming Cai, Meiming Lei, Fanzhang Zeng, Xiaofeng Zhu, Bofeng Front Pharmacol Pharmacology Cannabidiol, a non-psychoactive component extracted from the plant cannabis sativa, has gained growing focus in recent years since its extensive pharmacology effects have been founded. The purpose of this study intends to reveal the hot spots and frontiers of cannabidiol research using bibliometrics and data visualization methods. A total of 3,555 publications with 106,793 citations from 2004 to 2021 related to cannabidiol were retrieved in the Web of Science database, and the co-authorships, research categories, keyword burst, and reference citations in the cannabidiol field were analyzed and visualized by VOSviewer and Citespace software. Great importance has been attached to the pharmacology or pharmacy values of cannabidiol, especially in the treatment of neuropsychiatric disorders, such as epilepsy, anxiety, and schizophrenia. The mechanisms or targets of the cannabidiol have attracted the extreme interest of the researchers, a variety of receptors including cannabinoids type 1, cannabinoids type 2, 5-hydroxytriptamine1A, and G protein-coupled receptor 55 were involved in the pharmacology effects of cannabidiol. Moreover, the latest developed topic has focused on the positive effects of cannabidiol on substance use disorders. In conclusion, this study reveals the development and transformation of knowledge structures and research hotspots in the cannabidiol field from a bibliometrics perspective, exploring the possible directions of future research. Frontiers Media S.A. 2022-11-04 /pmc/articles/PMC9673983/ /pubmed/36408229 http://dx.doi.org/10.3389/fphar.2022.969883 Text en Copyright © 2022 Liu, Liu, Zhao, Cai, Lei, Zeng and Zhu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Liu, Liu Liu, Jianxing Zhao, Ming Cai, Meiming Lei, Fanzhang Zeng, Xiaofeng Zhu, Bofeng A bibliometrics and visualization analysis of cannabidiol research from 2004 to 2021 |
title | A bibliometrics and visualization analysis of cannabidiol research from 2004 to 2021 |
title_full | A bibliometrics and visualization analysis of cannabidiol research from 2004 to 2021 |
title_fullStr | A bibliometrics and visualization analysis of cannabidiol research from 2004 to 2021 |
title_full_unstemmed | A bibliometrics and visualization analysis of cannabidiol research from 2004 to 2021 |
title_short | A bibliometrics and visualization analysis of cannabidiol research from 2004 to 2021 |
title_sort | bibliometrics and visualization analysis of cannabidiol research from 2004 to 2021 |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673983/ https://www.ncbi.nlm.nih.gov/pubmed/36408229 http://dx.doi.org/10.3389/fphar.2022.969883 |
work_keys_str_mv | AT liuliu abibliometricsandvisualizationanalysisofcannabidiolresearchfrom2004to2021 AT liujianxing abibliometricsandvisualizationanalysisofcannabidiolresearchfrom2004to2021 AT zhaoming abibliometricsandvisualizationanalysisofcannabidiolresearchfrom2004to2021 AT caimeiming abibliometricsandvisualizationanalysisofcannabidiolresearchfrom2004to2021 AT leifanzhang abibliometricsandvisualizationanalysisofcannabidiolresearchfrom2004to2021 AT zengxiaofeng abibliometricsandvisualizationanalysisofcannabidiolresearchfrom2004to2021 AT zhubofeng abibliometricsandvisualizationanalysisofcannabidiolresearchfrom2004to2021 AT liuliu bibliometricsandvisualizationanalysisofcannabidiolresearchfrom2004to2021 AT liujianxing bibliometricsandvisualizationanalysisofcannabidiolresearchfrom2004to2021 AT zhaoming bibliometricsandvisualizationanalysisofcannabidiolresearchfrom2004to2021 AT caimeiming bibliometricsandvisualizationanalysisofcannabidiolresearchfrom2004to2021 AT leifanzhang bibliometricsandvisualizationanalysisofcannabidiolresearchfrom2004to2021 AT zengxiaofeng bibliometricsandvisualizationanalysisofcannabidiolresearchfrom2004to2021 AT zhubofeng bibliometricsandvisualizationanalysisofcannabidiolresearchfrom2004to2021 |